Contradictory results were presented by an investigation demonstrating that VDR deletion protected against liver steatosis, dyslipidemia, and insulin resistance in apolipoprotein E (apoE) knockout (−/−) HFD mice [67]. This evidence concerns the gene APOE and metabolic syndrome.